Oscar Health is poised for a significant turnaround in 2026 with strong revenue growth and improved profitability, potentially leading to a stock price of $25-$30 per share.
Source Post
Novo Nordisk ($NVO) Grind | UnitedHealth Group ($UNH) Recovery | Oscar Health ($OSCR) Growth
The RoseMar 15, 2026
The creator discusses three healthcare stocks: Novo Nordisk ($NVO), UnitedHealth Group ($UNH), and Oscar Health ($OSCR). Novo Nordisk is facing a near-term slowdown but is expected to rebound in 2027-2028. UnitedHealth Group is navigating industry shifts and policy changes, with potential for long-term recovery. Oscar Health shows strong revenue growth and promising guidance for 2026, suggesting significant upside potential in the short term.
Linked Mentions
Tickers discussed in this post
UnitedHealth Group is currently trading at a fair value but is expected to reach $400 per share by the end of 2026 due to anticipated EPS growth and a favorable forward PE ratio.
Novo Nordisk is expected to see a near-term decline in revenue and earnings for 2026, but the creator believes this is a worst-case scenario and anticipates a rebound in 2027-2028.